Printed from Voxsanity (voxsanity.com.au) — NCT07353840 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.
Back to Lymphoma
Lymphoma Trial, Recruiting
NCT07353840
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 to 70 years old at the time of signing the consent form
- People whose general physical functioning is rated at 0 or 1 on a standard health scale used by doctors (meaning fully active or able to carry out light activity), with no decline in the two weeks before joining
- People whose doctors estimate they have a life expectancy of at least 12 weeks
- People who have been confirmed through a tissue sample (biopsy) to have one of the following specific types of T-cell lymphoma: Peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS); ALK-negative anaplastic large cell lymphoma (ALK- ALCL); or follicular helper T-cell lymphoma / PTCL with a TFH pattern
- People whose lymphoma reached a complete response (meaning no detectable disease) after first-line chemotherapy with CHOP or a similar treatment regimen
- People whose liver and kidney blood test results fall within acceptable ranges as defined by the trial
- People whose heart pumping function (measured by a heart scan) is at or above 50%
- People who are willing and able to follow all trial procedures and have given their written informed consent
Who may not be able to join:
- People whose lymphoma is classified as Stage I (the earliest and most localised stage) according to a standard staging system
- People who have had another cancer in the past 5 years, except for certain slow-growing or easily treated skin cancers, early-stage bladder cancer, or non-invasive cancers of the prostate, cervix, or breast that were treated with the aim of a cure
- People with active or latent tuberculosis, based on a skin test result or chest imaging findings
- People with a known history of HIV infection or AIDS
- People with active hepatitis B, indicated by detectable hepatitis B virus DNA in the blood
- People with active hepatitis C, indicated by detectable hepatitis C virus RNA in the blood
- People with other active viral infections such as herpes zoster or cytomegalovirus (CMV)
- People with a serious infection currently requiring intravenous antibiotics or antiviral treatment
- People who test positive for the Epstein-Barr virus (EBV) on a blood test
- People with poorly controlled heart conditions, including moderate-to-severe heart failure, unstable chest pain (angina), a heart attack within the past year, or a significant irregular heartbeat requiring medical treatment
- People who are pregnant or breastfeeding, or people who are able to have children but are unwilling to use effective contraception during the trial
- People with psychiatric conditions or those who are unable to give informed consent
- People whom the trial doctor considers unsuitable for participation for any other medical reason
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
Contact this trial
Phone: +862163240090
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Status
Recruiting
Phase
Not Applicable
Sponsor
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Registry
ClinicalTrials.gov
Start date
20 January 2026
Est. completion
30 May 2029
Where this trial is recruiting
🇨🇳 China
Primary endpoints
event-free survival (EFS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.
Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.